HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma levels of atrial natriuretic factor in normal children and patients treated by hemodialysis and continuous ambulatory peritoneal dialysis.

Abstract
In an attempt to establish the reference data of plasma levels of atrial natriuretic factor (ANF) in different age groups and to evaluate plasma ANF changes before and after hemodialysis (HD) and during continuous ambulatory peritoneal dialysis (CAPD), fifty normal healthy children and 20 children with end-stage renal disease (ESRD) were included. Ten ESRD children received HD and 15 received CAPD therapy. Five cases received HD in the earlier period and then CAPD. The results showed that in normal children, at the age of under one month, there were higher plasma ANF levels. As age increased, plasma ANF levels progressively decreased. During the ESRD before dialysis, there was a significantly increased plasma ANF level (434.1 +/- 80.1 vs 17.5 +/- 2.3 pg/ml, P < 0.0001). Both HD and CAPD reduced the plasma ANF of patients to a lower degree, but the result was still higher than that in normal controls. There were significantly decreased plasma ANF level in the patients with CAPD therapy than those with HD (71.8 +/- 13.7 vs 270.3 +/- 51.9 pg/ml, P < 0.0001). The change of ANF levels was positively correlated with the body weight change and creatinine change after HD.
AuthorsL Y Yang, W P Chen, C Y Lin
JournalZhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui (Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi) 1993 Jan-Feb Vol. 34 Issue 1 Pg. 1-8 ISSN: 0001-6578 [Print] China (Republic : 1949- )
PMID8333281 (Publication Type: Journal Article)
Chemical References
  • Atrial Natriuretic Factor
Topics
  • Adolescent
  • Adult
  • Atrial Natriuretic Factor (blood)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Peritoneal Dialysis, Continuous Ambulatory
  • Renal Dialysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: